← All trials
NCT04729543
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 20, 2020
- Primary completion
- Oct 20, 2022
- Completion date
- Oct 20, 2027
- First posted
- Jan 28, 2021
- Last posted
- Jan 28, 2021
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Erasmus University RotterdamLead sponsor
- Erasmus University RotterdamReponsible party - principal investigator
- Dutch Cancer SocietyCollaborator
- Stichting Coolsingel Rotterdam grantCollaborator
- Ludwig Institute for Cancer ResearchCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.